神州細胞(688520.SH):子公司與關聯方簽訂租賃合同 租金總額不超2.9億元
格隆匯5月25日丨神州細胞(688520.SH)公佈,公司控股子公司神州細胞工程有限公司(稱“神州細胞工程”)與關聯方北京義翹神州科技股份有限公司(稱“義翹神州”)於2023年5月25日在北京簽訂租賃合同,承租義翹神州位於北京經濟技術開發區景園街8號天空之境產業廣場的房屋,租賃房屋建築面積不超過40,000平方米(含地上及地下部分),主要用作生產車間,部分用於研發、辦公等用途,首個租賃期限不超過6年,租金總額不超過人民幣2.9億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.